Hamilton Thorne Competitors

Viemed Healthcare (TSE:VMD) and Hamilton Thorne (CVE:HTL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations and institutional ownership.

Analyst Ratings

This is a summary of current recommendations for Viemed Healthcare and Hamilton Thorne, as provided by MarketBeat.

Hamilton Thorne has a consensus price target of C$1.87, indicating a potential upside of 6.86%. Given Hamilton Thorne's stronger consensus rating and higher possible upside, analysts plainly believe Hamilton Thorne is more favorable than Viemed Healthcare.

Profitability

This table compares Viemed Healthcare and Hamilton Thorne's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Viemed Healthcare and Hamilton Thorne's gross revenue, earnings per share (EPS) and valuation.

Viemed Healthcare has higher revenue and earnings than Hamilton Thorne. Viemed Healthcare is trading at a lower price-to-earnings ratio than Hamilton Thorne, indicating that it is currently the more affordable of the two stocks.

Summary

Hamilton Thorne beats Viemed Healthcare on 5 of the 8 factors compared between the two stocks.

Titan Medical (TSE:TMD) and Hamilton Thorne (CVE:HTL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations and institutional ownership.

Analyst Ratings

This is a summary of current recommendations for Titan Medical and Hamilton Thorne, as provided by MarketBeat.

Hamilton Thorne has a consensus price target of C$1.87, indicating a potential upside of 6.86%. Given Hamilton Thorne's higher possible upside, analysts plainly believe Hamilton Thorne is more favorable than Titan Medical.

Profitability

This table compares Titan Medical and Hamilton Thorne's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Titan Medical and Hamilton Thorne's gross revenue, earnings per share (EPS) and valuation.

Hamilton Thorne has higher revenue and earnings than Titan Medical. Titan Medical is trading at a lower price-to-earnings ratio than Hamilton Thorne, indicating that it is currently the more affordable of the two stocks.

Summary

Hamilton Thorne beats Titan Medical on 6 of the 7 factors compared between the two stocks.

Protech Home Medical (CVE:PTQ) and Hamilton Thorne (CVE:HTL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations and institutional ownership.

Analyst Ratings

This is a summary of current recommendations for Protech Home Medical and Hamilton Thorne, as provided by MarketBeat.

Protech Home Medical presently has a consensus price target of C$2.58, indicating a potential upside of 21.28%. Hamilton Thorne has a consensus price target of C$1.87, indicating a potential upside of 6.86%. Given Protech Home Medical's higher possible upside, equities analysts plainly believe Protech Home Medical is more favorable than Hamilton Thorne.

Profitability

This table compares Protech Home Medical and Hamilton Thorne's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Protech Home Medical and Hamilton Thorne's gross revenue, earnings per share (EPS) and valuation.

Hamilton Thorne has lower revenue, but higher earnings than Protech Home Medical. Protech Home Medical is trading at a lower price-to-earnings ratio than Hamilton Thorne, indicating that it is currently the more affordable of the two stocks.

Summary

Hamilton Thorne beats Protech Home Medical on 4 of the 7 factors compared between the two stocks.

Protech Home Medical (CVE:PHM) and Hamilton Thorne (CVE:HTL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations and institutional ownership.

Analyst Ratings

This is a summary of current recommendations for Protech Home Medical and Hamilton Thorne, as provided by MarketBeat.

Hamilton Thorne has a consensus price target of C$1.87, indicating a potential upside of 6.86%. Given Hamilton Thorne's higher possible upside, analysts plainly believe Hamilton Thorne is more favorable than Protech Home Medical.

Profitability

This table compares Protech Home Medical and Hamilton Thorne's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Protech Home Medical and Hamilton Thorne's gross revenue, earnings per share (EPS) and valuation.

Hamilton Thorne has lower revenue, but higher earnings than Protech Home Medical. Protech Home Medical is trading at a lower price-to-earnings ratio than Hamilton Thorne, indicating that it is currently the more affordable of the two stocks.

Summary

Hamilton Thorne beats Protech Home Medical on 6 of the 7 factors compared between the two stocks.

Helius Medical Technologies (TSE:HSM) and Hamilton Thorne (CVE:HTL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations and institutional ownership.

Analyst Ratings

This is a summary of current recommendations for Helius Medical Technologies and Hamilton Thorne, as provided by MarketBeat.

Hamilton Thorne has a consensus price target of C$1.87, indicating a potential upside of 6.86%. Given Hamilton Thorne's higher possible upside, analysts plainly believe Hamilton Thorne is more favorable than Helius Medical Technologies.

Earnings and Valuation

This table compares Helius Medical Technologies and Hamilton Thorne's gross revenue, earnings per share (EPS) and valuation.

Hamilton Thorne has higher revenue and earnings than Helius Medical Technologies. Helius Medical Technologies is trading at a lower price-to-earnings ratio than Hamilton Thorne, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Helius Medical Technologies and Hamilton Thorne's net margins, return on equity and return on assets.

Summary

Hamilton Thorne beats Helius Medical Technologies on 6 of the 7 factors compared between the two stocks.

Hamilton Thorne (CVE:HTL) and Aurora Spine (CVE:ASG) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, risk, valuation, institutional ownership, analyst recommendations and earnings.

Analyst Ratings

This is a summary of current recommendations and price targets for Hamilton Thorne and Aurora Spine, as reported by MarketBeat.

Hamilton Thorne currently has a consensus target price of C$1.87, indicating a potential upside of 6.86%. Given Hamilton Thorne's higher possible upside, analysts plainly believe Hamilton Thorne is more favorable than Aurora Spine.

Valuation & Earnings

This table compares Hamilton Thorne and Aurora Spine's gross revenue, earnings per share and valuation.

Hamilton Thorne has higher revenue and earnings than Aurora Spine. Aurora Spine is trading at a lower price-to-earnings ratio than Hamilton Thorne, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Hamilton Thorne and Aurora Spine's net margins, return on equity and return on assets.

Summary

Hamilton Thorne beats Aurora Spine on 7 of the 7 factors compared between the two stocks.